Skip to main content
Journal cover image

Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer.

Publication ,  Conference
Check, DK; Soneji, S; Cohen, HJ; Des Marais, A; Jones, KF; Gaber, CE; Merlin, JS; O'Regan, A; Fergestrom, N; Wilson, LE; Winn, AN
Published in: J Natl Cancer Inst
July 1, 2025

BACKGROUND: Many older adults with cancer are coprescribed opioids/benzodiazepines; evidence on harms is lacking. METHODS: Using SEER-Medicare (2012-2019), we identified patients with breast, colorectal, or lung cancer. Cox proportional hazards models estimated the adjusted hazard ratios (HRs) of coprescribing (measured from claims, at the day level) with the immediate risk of overdose, fall/fracture, and all-cause hospitalization. In a secondary analysis, models were stratified by ≥90 days of continuous medication supply. RESULTS: In our cohort of 107 288 patients, compared with those prescribed neither medication, those prescribed benzodiazepines had an increase in the immediate risk of falls/fractures (HR = 1.17, 95% CI = 1.02 to 1.34) and all-cause hospitalizations (HR = 1.08, 95% CI = 1.04 to 1.12). Patients prescribed opioids had an increase in the immediate risk of overdose (HR = 5.62, 95% CI = 4.86 to 5.62), falls/fractures (HR = 1.56, 95% CI = 1.41 to 1.73), and all-cause hospitalizations (HR = 1.26, 95% CI = 1.23 to 1.30). HRs were similar for patients coprescribed opioids/benzodiazepines. For patients without continuous exposure to 1 or both medications, effects were larger for coprescribed opioids/benzodiazepines vs opioids for overdose (HR = 15.22, 95% CI = 8.79 to 26.35 vs HR = 6.85, 95% CI = 6.85 to 26.35) and all-cause hospitalization (HR = 3.21, 95% CI = 2.60 to 3.96 vs HR = 1.98, 95% CI = 1.87 to 2.10). CONCLUSIONS: Overall, compared with no prescribing, benzodiazepine prescribing and opioid prescribing were each associated with an increase in the immediate risk of adverse events. Effects were similar for those prescribed opioids and those coprescribed opioids/benzodiazepines. For patients with intermittent vs long-term medication exposure, coprescribing additionally increased the risk of overdose and all-cause hospitalization.

Duke Scholars

Published In

J Natl Cancer Inst

DOI

EISSN

1460-2105

Publication Date

July 1, 2025

Volume

117

Issue

7

Start / End Page

1465 / 1473

Location

United States

Related Subject Headings

  • United States
  • SEER Program
  • Proportional Hazards Models
  • Oncology & Carcinogenesis
  • Neoplasms
  • Medicare
  • Male
  • Humans
  • Hospitalization
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Check, D. K., Soneji, S., Cohen, H. J., Des Marais, A., Jones, K. F., Gaber, C. E., … Winn, A. N. (2025). Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer. In J Natl Cancer Inst (Vol. 117, pp. 1465–1473). United States. https://doi.org/10.1093/jnci/djaf072
Check, Devon K., Samir Soneji, Harvey Jay Cohen, Andrea Des Marais, Katie F. Jones, Charles E. Gaber, Jessica S. Merlin, et al. “Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer.” In J Natl Cancer Inst, 117:1465–73, 2025. https://doi.org/10.1093/jnci/djaf072.
Check DK, Soneji S, Cohen HJ, Des Marais A, Jones KF, Gaber CE, et al. Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer. In: J Natl Cancer Inst. 2025. p. 1465–73.
Check, Devon K., et al. “Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer.J Natl Cancer Inst, vol. 117, no. 7, 2025, pp. 1465–73. Pubmed, doi:10.1093/jnci/djaf072.
Check DK, Soneji S, Cohen HJ, Des Marais A, Jones KF, Gaber CE, Merlin JS, O’Regan A, Fergestrom N, Wilson LE, Winn AN. Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer. J Natl Cancer Inst. 2025. p. 1465–1473.
Journal cover image

Published In

J Natl Cancer Inst

DOI

EISSN

1460-2105

Publication Date

July 1, 2025

Volume

117

Issue

7

Start / End Page

1465 / 1473

Location

United States

Related Subject Headings

  • United States
  • SEER Program
  • Proportional Hazards Models
  • Oncology & Carcinogenesis
  • Neoplasms
  • Medicare
  • Male
  • Humans
  • Hospitalization
  • Female